Gage Growth Corp., a leading high-quality cannabis premium brand and operator in Michigan, today announced that it has added a provisioning center (dispensary) to its portfolio located in Ann Arbor. The Company now has 18 provisioning center locations in its retail portfolio.
Gage’s first retail dispensary in Ann Arbor will be located at 2460 West Stadium Boulevard, a heavily trafficked area within three miles of downtown Ann Arbor and the University of Michigan campus. The Company will operate its newest location as a Cookies branded store and expects to begin serving patients and adult-use consumers in Q1 2022.
Since announcing its exclusive partnership with the international cannabis lifestyle brand in 2019, Gage has opened Cookies dispensaries in Detroit and Kalamazoo. In August 2021, Gage extended its existing agreement as Cookies’ exclusive cultivator, manufacturer and distributor in Michigan until 2026.
“Ann Arbor paved the way for Michigan’s first adult-use retail experience, and we are proud to introduce Cookies’ highly coveted retail experiences to the residents and visitors of this vibrant community,” said Fabian Monaco, CEO of Gage. “We look forward to bringing our portfolio of nationally-recognized brands to Ann Arbor while continuously strengthening Michigan’s position as a leading cannabis market in the U.S.”
About Gage Growth Corp.
Gage Growth Corp. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes three city and state cultivation and processing assets, and 18 provisioning centers (dispensaries).
Instagram: @gagemichigan
Facebook: @gageusa
Twitter: @gagecannabisco
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation.
Explanatory Note Regarding the Company’s Operations
References in this news release to the Company and its operations and portfolio are inclusive of the operations and assets of certain licensed cannabis operators that operate under the Gage brand pursuant to contractual arrangements with the Company. For additional information, please refer to the Company’s long form prospectus dated March 26, 2021 and other disclosure documents available on the Company’s profile at www.sedar.com.